Julien Bec1, Deborah Vela2, Jennifer E Phipps1, Michael Agung1, Jakob Unger1, Kenneth B Margulies3, Jeffrey A Southard4, L Maximilian Buja5, Laura Marcu6. 1. Department of Biomedical Engineering, University of California, Davis, California, USA. 2. Department of Cardiovascular Pathology Research, Texas Heart Institute, Houston, Texas, USA. 3. Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 4. Division of Cardiovascular Medicine, UC Davis Health System, University of California-Davis, Sacramento, California, USA. 5. Department of Cardiovascular Pathology Research, Texas Heart Institute, Houston, Texas, USA; Department of Pathology and Laboratory Medicine, the University of Texas Health Science Center at Houston, Houston, Texas, USA. 6. Department of Biomedical Engineering, University of California, Davis, California, USA. Electronic address: lmarcu@ucdavis.edu.
Abstract
OBJECTIVES: This study aimed to systematically investigate whether plaque autofluorescence properties assessed with intravascular fluorescence lifetime imaging (FLIm) can provide qualitative and quantitative information about intimal composition and improve the characterization of atherosclerosis lesions. BACKGROUND: Despite advances in cardiovascular diagnostics, the analytic tools and imaging technologies currently available have limited capabilities for evaluating in situ biochemical changes associated with luminal surface features. Earlier studies of small number of samples have shown differences among the autofluorescence lifetime signature of well-defined lesions, but a systematic pixel-level evaluation of fluorescence signatures associated with various histological features is lacking and needed to better understand the origins of fluorescence contrast. METHODS: Human coronary artery segments (n = 32) were analyzed with a bimodal catheter system combining multispectral FLIm with intravascular ultrasonography compatible with in vivo coronary imaging. Various histological components present along the luminal surface (200-μm depth) were systematically tabulated (12 sectors) from each serial histological section (n = 204). Morphological information provided by ultrasonography allowed for the accurate registration of imaging data with histology data. The relationships between histological findings and FLIm parameters obtained from 3 spectral channels at each measurement location (n = 33,980) were characterized. RESULTS: Our findings indicate that fluorescence lifetime from different spectral bands can be used to quantitatively predict the superficial presence of macrophage foam cells (mFCs) (area under the receiver-operator characteristic curve: 0.94) and extracellular lipid content in advanced lesions (lifetime increase in 540-nm band), detect superficial calcium (lifetime decrease in 450-nm band area under the receiver-operator characteristic curve: 0.90), and possibly detect lesions consistent with active plaque formation such as pathological intimal thickening and healed thrombus regions (lifetime increase in 390-nm band). CONCLUSIONS: Our findings indicate that autofluorescence lifetime provides valuable information for characterizing atherosclerotic lesions in coronary arteries. Specifically, FLIm can be used to identify key phenomena linked with plaque progression (e.g., peroxidized-lipid-rich mFC accumulation and recent plaque formation).
OBJECTIVES: This study aimed to systematically investigate whether plaque autofluorescence properties assessed with intravascular fluorescence lifetime imaging (FLIm) can provide qualitative and quantitative information about intimal composition and improve the characterization of atherosclerosis lesions. BACKGROUND: Despite advances in cardiovascular diagnostics, the analytic tools and imaging technologies currently available have limited capabilities for evaluating in situ biochemical changes associated with luminal surface features. Earlier studies of small number of samples have shown differences among the autofluorescence lifetime signature of well-defined lesions, but a systematic pixel-level evaluation of fluorescence signatures associated with various histological features is lacking and needed to better understand the origins of fluorescence contrast. METHODS: Human coronary artery segments (n = 32) were analyzed with a bimodal catheter system combining multispectral FLIm with intravascular ultrasonography compatible with in vivo coronary imaging. Various histological components present along the luminal surface (200-μm depth) were systematically tabulated (12 sectors) from each serial histological section (n = 204). Morphological information provided by ultrasonography allowed for the accurate registration of imaging data with histology data. The relationships between histological findings and FLIm parameters obtained from 3 spectral channels at each measurement location (n = 33,980) were characterized. RESULTS: Our findings indicate that fluorescence lifetime from different spectral bands can be used to quantitatively predict the superficial presence of macrophage foam cells (mFCs) (area under the receiver-operator characteristic curve: 0.94) and extracellular lipid content in advanced lesions (lifetime increase in 540-nm band), detect superficial calcium (lifetime decrease in 450-nm band area under the receiver-operator characteristic curve: 0.90), and possibly detect lesions consistent with active plaque formation such as pathological intimal thickening and healed thrombus regions (lifetime increase in 390-nm band). CONCLUSIONS: Our findings indicate that autofluorescence lifetime provides valuable information for characterizing atherosclerotic lesions in coronary arteries. Specifically, FLIm can be used to identify key phenomena linked with plaque progression (e.g., peroxidized-lipid-rich mFC accumulation and recent plaque formation).
Authors: Jesung Park; Paritosh Pande; Sebina Shrestha; Fred Clubb; Brian E Applegate; Javier A Jo Journal: Atherosclerosis Date: 2011-11-15 Impact factor: 5.162
Authors: Fumiyuki Otsuka; Miranda C A Kramer; Pier Woudstra; Kazuyuki Yahagi; Elena Ladich; Aloke V Finn; Robbert J de Winter; Frank D Kolodgie; Thomas N Wight; Harry R Davis; Michael Joner; Renu Virmani Journal: Atherosclerosis Date: 2015-05-19 Impact factor: 5.162
Authors: Wei Li; Mattias Ostblom; Li-Hua Xu; Anna Hellsten; Per Leanderson; Bo Liedberg; Ulf T Brunk; John W Eaton; Xi-Ming Yuan Journal: FASEB J Date: 2006-11 Impact factor: 5.191
Authors: Julien Bec; Jennifer E Phipps; Dimitris Gorpas; Dinglong Ma; Hussain Fatakdawala; Kenneth B Margulies; Jeffrey A Southard; Laura Marcu Journal: Sci Rep Date: 2017-08-21 Impact factor: 4.379
Authors: Anantharaman Ramasamy; Patrick W Serruys; Daniel A Jones; Thomas W Johnson; Ryo Torii; Sean P Madden; Rajiv Amersey; Rob Krams; Andreas Baumbach; Anthony Mathur; Christos V Bourantas Journal: Am Heart J Date: 2019-07-23 Impact factor: 4.749